Godrej Agrovet Ltd

Godrej Agrovet Limited has announced that its Board of Directors will convene on Friday, November 6, 2026. The primary agenda item for this meeting is to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2026. This review will take place after the Audit Committee has examined the results. The company has also made this information available on its website.

Godrej Agrovet Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from October 1, 2026, and will remain in effect until 48 hours after the declaration of the Unaudited Standalone & Consolidated Financial Results for the quarter and half-year ending September 30, 2026. The decision aligns with the Company's Code of Conduct for Prohibition of Insider Trading, as per SEBI regulations. All designated employees and directors are prohibited from trading in the company's equity shares during this period.

Godrej Agrovet Limited's Nomination and Remuneration Committee has noted the lapse of 10,958 stock options previously granted under the Employees Stock Grant Scheme 2018 (ESGS 2018). These options lapsed due to the cessation of employment of the eligible employees. The committee also approved the grant of 3,347 new stock options under the same scheme to other eligible employees at an exercise price of Rs. 10 per option. These new options will vest over three years.

Godrej Agrovet Limited has announced the grant of 3,347 stock options under its Employees Stock Grant Scheme 2018 (ESGS 2018) to eligible employees. The exercise price for these options is ₹10 per option, with each option convertible into one equity share of face value ₹10. The options will vest over three years and are exercisable within one month of vesting. Additionally, the company noted the lapse of 10,958 stock options due to employee cessation. This move is part of the company's long-term employee incentive strategy.

Godrej Agrovet Limited announced changes in its Senior Management Personnel. Mr. Rajavelu N.K., Chief Executive Officer of the Crop Care Business, has resigned, effective November 24, 2026, to pursue an external opportunity. The Board of Directors has appointed Mr. Sivaram Yadavalli, Head – Strategy & Business Development, as the Interim Chief Executive Officer – Crop Care Business, effective November 25, 2026. This change is a direct consequence of Mr. Rajavelu's resignation. Mr. Yadavalli will continue his role as Head – Strategy & Business Development.

Godrej Agrovet Limited announced changes in its Senior Management Personnel. Mr. Rajavelu N.K., Chief Executive Officer of the Crop Care Business, has resigned, with his last day being November 24, 2026. He is pursuing an external opportunity. Concurrently, Mr. Sivaram Yadavalli, Head – Strategy & Business Development, has been appointed as the Interim Chief Executive Officer – Crop Care Business, effective November 25, 2026. This appointment is a direct consequence of Mr. Rajavelu's resignation. The company has also made the information available on its website.

Godrej Agrovet Ltd announced the appointment of Ms. Anushree Singh as the new Chief Human Resources Officer (CHRO) of the company, effective September 7, 2026. This appointment follows the cessation of employment of Ms. Mallika Mutreja as Head – Human Resources. Ms. Singh brings over two decades of global HR leadership experience, including her recent role as CHRO at JSW Energy, where she played a key role in scaling the organization and implementing HR strategies. Her expertise spans people strategy, organizational transformation, and leadership development across various industries and geographies. The company has also made the required disclosures regarding her appointment available on its website and in an annexure to the filing.

Godrej Agrovet Ltd has responded to a BSE query regarding a significant increase in its securities' trading volume. The company stated that it is compliant with all disclosure requirements under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, and the Prohibition of Insider Trading Regulations, 2015. Godrej Agrovet confirmed that no material developments requiring mandatory disclosure have occurred. They assured the exchange of their commitment to responsible corporate conduct and timely disclosures as per applicable regulations.

Godrej Agrovet Limited announced the allotment of 51,423 equity shares to eligible employees under its Employees Stock Grant Scheme 2018 (ESGS 2018). This allotment, valued at ₹5,14,230, increased the company's paid-up equity share capital to ₹192,41,13,900. Concurrently, the Nomination and Remuneration Committee noted the lapse of 10,329 stock options previously granted under the same scheme, primarily due to cessation of employment. The newly allotted shares will rank pari passu with existing equity shares.

Godrej Agrovet Limited (GAVL) announced its financial results for the first quarter ended June 30, 2026. Consolidated sales reached ₹2,852 crore, a growth from ₹2,603 crore in Q1 FY26. Profit before tax (excluding non-recurring items) stood at ₹172 crore, down from ₹188 crore in the prior year's quarter. The company cited delayed monsoons and geopolitical tensions leading to inflationary pressures as key challenges impacting profitability, particularly in the Crop Care business. However, Animal Nutrition and Oil Palm businesses showed strong performance, with double-digit volume growth in cattle feed and improved realizations in oil palm. Astec LifeSciences is progressing on its turnaround, achieving EBITDA break-even. The Dairy business saw increased value-added product share, and Godrej Foods maintained stable revenues despite input cost pressures.